{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:45:56Z","timestamp":1787499956460,"version":"build-2736575974"},"reference-count":93,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["22UQU4280107DSR01"],"award-info":[{"award-number":["22UQU4280107DSR01"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Biology"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13880209.2022.2039215","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T09:12:38Z","timestamp":1646212358000},"page":"509-524","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["The vital role of animal, marine, and microbial natural products against COVID-19"],"prefix":"10.1080","volume":"60","author":[{"given":"Aljawharah A.","family":"Alqathama","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Natural Products and Alternative Medicines, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba B.","family":"Alsaedi","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad A.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekram H.","family":"Abkar","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola H.","family":"Alrehaly","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf N.","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/md19050242"},{"key":"e_1_3_3_3_1","first-page":"1989","article-title":"Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis","volume":"64","author":"Abdo N","year":"2021","unstructured":"Abdo N, Moheyeldin O, Shehata MG, El Sohaimy S. 2021. Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis. Egypt J Chem. 64:1989\u20132001.","journal-title":"Egypt J Chem"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/1559325820982423"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X20976293"},{"issue":"4","key":"e_1_3_3_6_1","first-page":"19","article-title":"Rutin: a potential antiviral for repurposing as a SARS-CoV-2 main protease (Mpro) inhibitor","volume":"16","author":"Agrawal PK","year":"2021","unstructured":"Agrawal PK, Agrawal C, Blunden G. 2021. Rutin: a potential antiviral for repurposing as a SARS-CoV-2 main protease (Mpro) inhibitor. Nat Prod Commun. 16(4):19.","journal-title":"Nat Prod Commun"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2020.08.004"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155224"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030307"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S306441"},{"issue":"624657","key":"e_1_3_3_11_1","first-page":"624657","article-title":"Stimulating the resolution of inflammation through Omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F trial","volume":"11","author":"Arnardottir H","year":"2020","unstructured":"Arnardottir H, Pawelzik SC, \u00d6hlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, B\u00e4ck M. 2020. Stimulating the resolution of inflammation through Omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F trial. Front Physiol. 11(624657):624657.","journal-title":"Front Physiol"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1921032"},{"issue":"24","key":"e_1_3_3_13_1","first-page":"1","article-title":"Potent in\u00a0vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin","volume":"1","author":"Ashhurst AS","year":"2020","unstructured":"Ashhurst AS, Tang AH, Fajtov\u00e1 P, Yoon M, Aggarwal A, Stoye A, Larance M, Beretta L, Drelich A, Skinner D, et\u00a0al. 2020. Potent in\u00a0vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin. L. bioRxiv. 1(24):1\u201326.","journal-title":"L. bioRxiv"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110622"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00901-9"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-020-00305-3"},{"issue":"1","key":"e_1_3_3_17_1","first-page":"132","article-title":"Bal Arisi Zehr\u0130n\u0130n Kompoz\u0130syonunu Ve \u00dcret\u0130m M\u0130ktarini Etk\u0130leyen Fakt\u00f6rler","volume":"21","author":"Caprazli T","year":"2021","unstructured":"Caprazli T, Keke\u00e7o\u011flu M. 2021. Bal Arisi Zehr\u0130n\u0130n Kompoz\u0130syonunu Ve \u00dcret\u0130m M\u0130ktarini Etk\u0130leyen Fakt\u00f6rler. Uludag Aricilik Derg. 21(1):132\u2013145.","journal-title":"Uludag Aricilik Derg"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1RA00644D"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26051200"},{"key":"e_1_3_3_20_1","unstructured":"ClinicalTrials. 2021. Effect of quercetin on prophylaxis and treatment of COVID-19. 2020. Bethesda (MD): ClinicalTrials. Gov; [accessed 2021 May 10]. https:\/\/clinicaltrials.gov\/."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240079"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S318720"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/md18070338"},{"issue":"2593","key":"e_1_3_3_24_1","first-page":"1","article-title":"The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens","volume":"11","author":"Duan L","year":"2020","unstructured":"Duan L, Zheng Q, Zhang H, Niu Y, Lou Y, Wang H. 2020. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. Front Immunol. 11(2593):1\u201312.","journal-title":"Front Immunol"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11030460"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761881"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/md19010004"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02107-3"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/md19080409"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/md18040225"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8050129"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21732"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12030195"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-021-02351-1"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109957"},{"issue":"1161","key":"e_1_3_3_36_1","first-page":"1","article-title":"Marine sponge is a promising natural source of anti-SARS-CoV-2 scaffold","volume":"12","author":"Hamoda AM","year":"2021","unstructured":"Hamoda AM, Fayed B, Ashmawy NS, El-Shorbagi A-NA, Hamdy R, Soliman SSM. 2021. Marine sponge is a promising natural source of anti-SARS-CoV-2 scaffold. Front Pharmacol. 12(1161):1\u20139.","journal-title":"Front Pharmacol"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2020-0124"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00773-9"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","unstructured":"Hashem H. 2020. In silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors. Eurasian J Med Oncol. 4(3): 196\u2013200.","DOI":"10.26434\/chemrxiv.12115359"},{"issue":"3","key":"e_1_3_3_40_1","first-page":"e7355","article-title":"Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment","volume":"12","author":"Hassan SA","year":"2020","unstructured":"Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. 2020. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 12(3):e7355.","journal-title":"Cureus"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2020.52.4.478"},{"issue":"6","key":"e_1_3_3_42_1","first-page":"1","article-title":"Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor","volume":"16","author":"Hu X","year":"2020","unstructured":"Hu X, Cai X, Song X, Li C, Zhao J, Luo W, Zhang Q, Ekumi IO, He Z. 2020. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. 16(6):1\u201310.","journal-title":"Future Virol"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2020.11.049"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25040911"},{"issue":"14","key":"e_1_3_3_45_1","first-page":"1","article-title":"Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease","volume":"39","author":"Kandeel M","year":"2020","unstructured":"Kandeel M, Abdelrahman AHM, Oh-Hashi K, Ibrahim A, Venugopala KN, Morsy MA, Ibrahim MAA. 2020. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease. J Biomol Struct Dyn. 39(14):1\u20138.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-020-00271-z"},{"issue":"1","key":"e_1_3_3_47_1","first-page":"1","article-title":"Beta-Sitosterol: as immunostimulant, antioxidant and inhibitor of SARS-CoV-2 spike glycoprotein","volume":"2","author":"Khan SL","year":"2020","unstructured":"Khan SL, Siddiqui FA. 2020. Beta-Sitosterol: as immunostimulant, antioxidant and inhibitor of SARS-CoV-2 spike glycoprotein. Arch Pharmacol Thera. 2(1):1\u20135.","journal-title":"Arch Pharmacol Thera"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772108"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21487"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.spid.2004.02.001"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6872"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12100618"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.171700"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2221-1691(11)60016-6"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153286"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01402-1"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa378"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237480"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173759"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114215"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26071924"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-020-02437-9"},{"issue":"3","key":"e_1_3_3_64_1","first-page":"1","article-title":"Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): an update","volume":"12","author":"Pal M","year":"2020","unstructured":"Pal M, Berhanu G, Desalegn C, Kandi V. 2020. Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): an update. Cureus. 12(3):1\u201313.","journal-title":"Cureus"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.04.026"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13091"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2021.01.006"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25102271"},{"key":"e_1_3_3_69_1","article-title":"Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro): a molecular docking and simulation approach to combat COVID-19","author":"Rehman MT","year":"2020","unstructured":"Rehman MT, AlAjmi MF, Hussain A. 2020. Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro): a molecular docking and simulation approach to combat COVID-19. Curr Pharm Des. 27:3577\u20133589.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.07.005"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.09.035"},{"issue":"1","key":"e_1_3_3_72_1","first-page":"1","article-title":"Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2","volume":"10","author":"Saakre M","year":"2021","unstructured":"Saakre M, Mathew D, Ravisankar V. 2021. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni-Seuf Univ J Appl. 10(1):1\u201313.","journal-title":"Beni-Seuf Univ J Appl"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.05.012"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-020-00642-7"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12041-021-01262-w"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129433"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106054"},{"issue":"1","key":"e_1_3_3_78_1","first-page":"1","article-title":"Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in\u00a0vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor","volume":"12","author":"Siniavin AE","year":"2021","unstructured":"Siniavin AE, Nikiforova MA, Grinkina SD, Gushchin VA, Starkov VG, Osipov AV, Tsetlin VI, Utkin YN. 2021. Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in\u00a0vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor. bioRxiv. 12(1):1\u201327.","journal-title":"bioRxiv"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0FO02017F"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0RA06379G"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/md19020104"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v5i1.377"},{"key":"e_1_3_3_83_1","unstructured":"Usefulness of topic ivermectin and carrageenan to prevent contagion of Covid 19 (IVERCAR). 2020. Bethesda (MD): ClinicalTrials. Gov 2021; [accessed 2021 Jun 20]. https:\/\/clinicaltrials.gov\/."},{"issue":"4","key":"e_1_3_3_84_1","first-page":"1","article-title":"Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19","volume":"38","author":"Verma AK.","year":"2020","unstructured":"Verma AK. 2020. Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19. J Biomol Structure Dynam. 38(4):1\u20138.","journal-title":"J Biomol Structure Dynam"},{"issue":"4","key":"e_1_3_3_85_1","first-page":"1","article-title":"Bioactive compounds from marine resources against novel corona virus (2019-nCoV): In silico study for corona viral drug","volume":"34","author":"Vijayaraj R","year":"2020","unstructured":"Vijayaraj R, Altaff K, Rosita AS, Ramadevi S, Revathy J. 2020. Bioactive compounds from marine resources against novel corona virus (2019-nCoV): In silico study for corona viral drug. Nat Prod Res. 34(4):1\u20135.","journal-title":"Nat Prod Res"},{"key":"e_1_3_3_86_1","unstructured":"Vitamin D omega-3 and combination vitamins B C and zinc supplementation for the treatment and prevention of COVID-19. 2021. Bethesda (MD): ClinicalTrials. Gov; [accessed 2021 May 12]. https:\/\/clinicaltrials.gov\/."},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26030711"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/140293"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-141604485-7.50031-7"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4058"},{"key":"e_1_3_3_91_1","unstructured":"WHO coronavirus (COVID-19) dashboard. 2021. Geneva: World Health Organization; [accessed 2021 Feb 12]. https:\/\/www.who.int\/."},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040821"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104016"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21815"}],"container-title":["Pharmaceutical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13880209.2022.2039215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:20:34Z","timestamp":1728552034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13880209.2022.2039215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13880209.2022.2039215"],"URL":"https:\/\/doi.org\/10.1080\/13880209.2022.2039215","relation":{},"ISSN":["1388-0209","1744-5116"],"issn-type":[{"value":"1388-0209","type":"print"},{"value":"1744-5116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}